Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
Issued Date
2024-01-01
Resource Type
eISSN
20597029
Scopus ID
2-s2.0-85186220766
Journal Title
ESMO Open
Rights Holder(s)
SCOPUS
Bibliographic Citation
ESMO Open (2024)
Suggested Citation
Shitara K., Fleitas T., Kawakami H., Curigliano G., Narita Y., Wang F., Wardhani S.O., Basade M., Rha S.Y., Wan Zamaniah W.I., Sacdalan D.L., Ng M., Yeh K.H., Sunpaweravong P., Sirachainan E., Chen M.H., Yong W.P., Peneyra J.L., Ibtisam M.N., Lee K.W., Krishna V., Pribadi R.R., Li J., Lui A., Yoshino T., Baba E., Nakayama I., Pentheroudakis G., Shoji H., Cervantes A., Ishioka C., Smyth E. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer. ESMO Open (2024). doi:10.1016/j.esmoop.2023.102226 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/97493
Title
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
Author(s)
Shitara K.
Fleitas T.
Kawakami H.
Curigliano G.
Narita Y.
Wang F.
Wardhani S.O.
Basade M.
Rha S.Y.
Wan Zamaniah W.I.
Sacdalan D.L.
Ng M.
Yeh K.H.
Sunpaweravong P.
Sirachainan E.
Chen M.H.
Yong W.P.
Peneyra J.L.
Ibtisam M.N.
Lee K.W.
Krishna V.
Pribadi R.R.
Li J.
Lui A.
Yoshino T.
Baba E.
Nakayama I.
Pentheroudakis G.
Shoji H.
Cervantes A.
Ishioka C.
Smyth E.
Fleitas T.
Kawakami H.
Curigliano G.
Narita Y.
Wang F.
Wardhani S.O.
Basade M.
Rha S.Y.
Wan Zamaniah W.I.
Sacdalan D.L.
Ng M.
Yeh K.H.
Sunpaweravong P.
Sirachainan E.
Chen M.H.
Yong W.P.
Peneyra J.L.
Ibtisam M.N.
Lee K.W.
Krishna V.
Pribadi R.R.
Li J.
Lui A.
Yoshino T.
Baba E.
Nakayama I.
Pentheroudakis G.
Shoji H.
Cervantes A.
Ishioka C.
Smyth E.
Author's Affiliation
Centro de Investigación Biomédica en Red de Cáncer
Graduate School of Medical Sciences
Oxford University Hospitals NHS Foundation Trust
Yonsei Cancer Hospital
Seoul National University Bundang Hospital
Sun Yat-Sen University Cancer Center
Tongji University
National Taiwan University Hospital
University of the Philippines Manila
Breach Candy Hospital
Brawijaya University
Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo
Cancer Institute Hospital of Japan Foundation for Cancer Research
National Cancer Centre, Singapore
Kindai University School of Medicine
Istituto Europeo di Oncologia
Università degli Studi di Milano
Universiti Malaya
Aichi Cancer Center Hospital and Research Institute
Kuala Lumpur Hospital
Faculty of Medicine, Prince of Songkla University
National Taiwan University College of Medicine
National Cancer Center Hospital
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Hospital Clinico Universitario de Valencia
Taipei Veterans General Hospital
Tohoku University Hospital
National Cancer Center Hospital East
Universitat de València
Southern Philippines Medical Center
National University Cancer Institute
San Juan De Dios Educational Foundation Inc
AIG Hospitals
ESMO
Graduate School of Medical Sciences
Oxford University Hospitals NHS Foundation Trust
Yonsei Cancer Hospital
Seoul National University Bundang Hospital
Sun Yat-Sen University Cancer Center
Tongji University
National Taiwan University Hospital
University of the Philippines Manila
Breach Candy Hospital
Brawijaya University
Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo
Cancer Institute Hospital of Japan Foundation for Cancer Research
National Cancer Centre, Singapore
Kindai University School of Medicine
Istituto Europeo di Oncologia
Università degli Studi di Milano
Universiti Malaya
Aichi Cancer Center Hospital and Research Institute
Kuala Lumpur Hospital
Faculty of Medicine, Prince of Songkla University
National Taiwan University College of Medicine
National Cancer Center Hospital
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Hospital Clinico Universitario de Valencia
Taipei Veterans General Hospital
Tohoku University Hospital
National Cancer Center Hospital East
Universitat de València
Southern Philippines Medical Center
National University Cancer Institute
San Juan De Dios Educational Foundation Inc
AIG Hospitals
ESMO
Corresponding Author(s)
Other Contributor(s)
Abstract
The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer (GC), published in late 2022 and the updated ESMO Gastric Cancer Living Guideline published in July 2023, were adapted in August 2023, according to previously established standard methodology, to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for the management of Asian patients with GC. The adapted guidelines presented in this manuscript represent the consensus opinions reached by a panel of Asian experts in the treatment of patients with GC representing the oncological societies of China (CSCO), Indonesia (ISHMO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO), coordinated by ESMO and the Japanese Society of Medical Oncology (JSMO). The voting was based on scientific evidence and was independent of the current treatment practices, drug access restrictions and reimbursement decisions in the different Asian regions represented by the 10 oncological societies. The latter are discussed separately in the manuscript. The aim is to provide guidance for the optimisation and harmonisation of the management of patients with GC across the different regions of Asia, drawing on the evidence provided by both Western and Asian trials, whilst respecting the differences in screening practices, molecular profiling and age and stage at presentation. Attention is drawn to the disparity in the drug approvals and reimbursement strategies, between the different regions of Asia.